Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes

Endocrine autoimmune disorders are mediated by T cell-dependent responses to organ-specific antigens, but the mechanisms initiating the process remain unknown. Lymphocytes which use the gamma delta heterodimer as T cell receptor (TCR) for antigen constitute a distinct subset of T cells whose functio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental immunology 1993-05, Vol.92 (2), p.288-295
Hauptverfasser: Roura-Mir, I C, Alcalde, L, Vargas, F, Tolosa, E, Obiols, G, Foz, M, Jaraquemada, D, Pujol-Borrell, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 295
container_issue 2
container_start_page 288
container_title Clinical and experimental immunology
container_volume 92
creator Roura-Mir, I C
Alcalde, L
Vargas, F
Tolosa, E
Obiols, G
Foz, M
Jaraquemada, D
Pujol-Borrell, R
description Endocrine autoimmune disorders are mediated by T cell-dependent responses to organ-specific antigens, but the mechanisms initiating the process remain unknown. Lymphocytes which use the gamma delta heterodimer as T cell receptor (TCR) for antigen constitute a distinct subset of T cells whose function remains elusive. In order to investigate their possible involvement in endocrine autoimmunity we have determined the proportion of gamma delta T cells in the peripheral blood of 23 patients with type 1 (insulin-dependent) diabetes mellitus (type-1 DM) and 30 patients with autoimmune thyrotoxicosis (Graves' disease). T lymphocyte TCR expression was assessed by fluorescence-activated flow cytometry on peripheral blood mononuclear cells using MoAbs UCHT1 (CD3), TCR delta 1 (gamma delta TCR), WT31 and beta F1 (alpha beta TCR) and both the percentage of T cells expressing gamma delta and the ratio gamma delta/alpha beta were calculated. In the diabetic patients gamma delta cells were not significantly different from the control group (7.7 +/- 54% versus 8.0 +/- 5.5% of T cells, P NS). There was no relation between the proportion of gamma delta lymphocytes and the presence of islet cell antibodies (ICA) in the sera. The Graves' patients showed a tendency towards a higher proportion of gamma delta T lymphocytes than the controls (gamma delta/alpha beta ratios: 0.095 +/- 0.047 versus 0.063 +/- 0.022, P = 0.03). In 14 Graves' patients the number of gamma delta were measured in paired samples of peripheral and intrathyroidal lymphocytes, demonstrating an expansion of gamma delta within the thyroid glands (0.21 +/- 0.3 versus 0.095 +/- 0.047, P = 0.032). Immunohistochemical studies showed that gamma delta cells were scattered among the predominant alpha beta lymphocytes infiltrating the thyroid gland and that they account for 10% of intraepithelial lymphocytes. No relation was found between the increase of gamma delta lymphocytes and any clinical features.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1554822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75722431</sourcerecordid><originalsourceid>FETCH-LOGICAL-p224t-ff8c1bd694373a7f73e7d786456943e42701a89e7ec6a4e52ebba7c85ff1e5ed3</originalsourceid><addsrcrecordid>eNqFkU9LxDAQxYso67r6EYSc9FRo2vxpPQiy6CoseNFzmSZTN9ImtUmL_fZ2cRE9eRpm3psfb5ijaEkzweM0ZcVxtEySpIgLmrDT6Mz797kVQqSLaJGznBeUL6NxA20LRGMTgDRT2-2cmgJ6YixBq53qjUUCQ3CmbQdrwnRDcDQarULiaoKfHVhvnN0vbHoY0V8TbTyCR1INgVgX9lKYOiR0VqDCGX8endTQeLw41FX0-nD_sn6Mt8-bp_XdNu7mC0Jc17milRYFy2QGspYZSi1zwfh-hCyVCYW8QIlKAEOeYlWBVDmva4ocdbaKbr-53VC1qBXa0ENTdr1poZ9KB6b8q1izK9_cWFLOWZ6mM-DqAOjdx4A-lK3xCpsGLLrBl5LLOWlG_zVSwQqWUjEbL39H-slyeEn2BYvti-w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16494216</pqid></control><display><type>article</type><title>Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Roura-Mir, I C ; Alcalde, L ; Vargas, F ; Tolosa, E ; Obiols, G ; Foz, M ; Jaraquemada, D ; Pujol-Borrell, R</creator><creatorcontrib>Roura-Mir, I C ; Alcalde, L ; Vargas, F ; Tolosa, E ; Obiols, G ; Foz, M ; Jaraquemada, D ; Pujol-Borrell, R</creatorcontrib><description>Endocrine autoimmune disorders are mediated by T cell-dependent responses to organ-specific antigens, but the mechanisms initiating the process remain unknown. Lymphocytes which use the gamma delta heterodimer as T cell receptor (TCR) for antigen constitute a distinct subset of T cells whose function remains elusive. In order to investigate their possible involvement in endocrine autoimmunity we have determined the proportion of gamma delta T cells in the peripheral blood of 23 patients with type 1 (insulin-dependent) diabetes mellitus (type-1 DM) and 30 patients with autoimmune thyrotoxicosis (Graves' disease). T lymphocyte TCR expression was assessed by fluorescence-activated flow cytometry on peripheral blood mononuclear cells using MoAbs UCHT1 (CD3), TCR delta 1 (gamma delta TCR), WT31 and beta F1 (alpha beta TCR) and both the percentage of T cells expressing gamma delta and the ratio gamma delta/alpha beta were calculated. In the diabetic patients gamma delta cells were not significantly different from the control group (7.7 +/- 54% versus 8.0 +/- 5.5% of T cells, P NS). There was no relation between the proportion of gamma delta lymphocytes and the presence of islet cell antibodies (ICA) in the sera. The Graves' patients showed a tendency towards a higher proportion of gamma delta T lymphocytes than the controls (gamma delta/alpha beta ratios: 0.095 +/- 0.047 versus 0.063 +/- 0.022, P = 0.03). In 14 Graves' patients the number of gamma delta were measured in paired samples of peripheral and intrathyroidal lymphocytes, demonstrating an expansion of gamma delta within the thyroid glands (0.21 +/- 0.3 versus 0.095 +/- 0.047, P = 0.032). Immunohistochemical studies showed that gamma delta cells were scattered among the predominant alpha beta lymphocytes infiltrating the thyroid gland and that they account for 10% of intraepithelial lymphocytes. No relation was found between the increase of gamma delta lymphocytes and any clinical features.</description><identifier>ISSN: 0009-9104</identifier><identifier>EISSN: 1365-2249</identifier><identifier>PMID: 8485915</identifier><language>eng</language><publisher>England</publisher><subject>Adolescent ; Adult ; Age Factors ; Autoimmune Diseases - immunology ; Child ; Diabetes Mellitus, Type 1 - immunology ; Female ; Fluorescent Antibody Technique ; Graves Disease - immunology ; Humans ; Immunophenotyping ; Male ; Middle Aged ; Receptors, Antigen, T-Cell, gamma-delta - immunology ; T-Lymphocyte Subsets - immunology ; Thyroid Gland - immunology</subject><ispartof>Clinical and experimental immunology, 1993-05, Vol.92 (2), p.288-295</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1554822/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1554822/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8485915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roura-Mir, I C</creatorcontrib><creatorcontrib>Alcalde, L</creatorcontrib><creatorcontrib>Vargas, F</creatorcontrib><creatorcontrib>Tolosa, E</creatorcontrib><creatorcontrib>Obiols, G</creatorcontrib><creatorcontrib>Foz, M</creatorcontrib><creatorcontrib>Jaraquemada, D</creatorcontrib><creatorcontrib>Pujol-Borrell, R</creatorcontrib><title>Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes</title><title>Clinical and experimental immunology</title><addtitle>Clin Exp Immunol</addtitle><description>Endocrine autoimmune disorders are mediated by T cell-dependent responses to organ-specific antigens, but the mechanisms initiating the process remain unknown. Lymphocytes which use the gamma delta heterodimer as T cell receptor (TCR) for antigen constitute a distinct subset of T cells whose function remains elusive. In order to investigate their possible involvement in endocrine autoimmunity we have determined the proportion of gamma delta T cells in the peripheral blood of 23 patients with type 1 (insulin-dependent) diabetes mellitus (type-1 DM) and 30 patients with autoimmune thyrotoxicosis (Graves' disease). T lymphocyte TCR expression was assessed by fluorescence-activated flow cytometry on peripheral blood mononuclear cells using MoAbs UCHT1 (CD3), TCR delta 1 (gamma delta TCR), WT31 and beta F1 (alpha beta TCR) and both the percentage of T cells expressing gamma delta and the ratio gamma delta/alpha beta were calculated. In the diabetic patients gamma delta cells were not significantly different from the control group (7.7 +/- 54% versus 8.0 +/- 5.5% of T cells, P NS). There was no relation between the proportion of gamma delta lymphocytes and the presence of islet cell antibodies (ICA) in the sera. The Graves' patients showed a tendency towards a higher proportion of gamma delta T lymphocytes than the controls (gamma delta/alpha beta ratios: 0.095 +/- 0.047 versus 0.063 +/- 0.022, P = 0.03). In 14 Graves' patients the number of gamma delta were measured in paired samples of peripheral and intrathyroidal lymphocytes, demonstrating an expansion of gamma delta within the thyroid glands (0.21 +/- 0.3 versus 0.095 +/- 0.047, P = 0.032). Immunohistochemical studies showed that gamma delta cells were scattered among the predominant alpha beta lymphocytes infiltrating the thyroid gland and that they account for 10% of intraepithelial lymphocytes. No relation was found between the increase of gamma delta lymphocytes and any clinical features.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Autoimmune Diseases - immunology</subject><subject>Child</subject><subject>Diabetes Mellitus, Type 1 - immunology</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>Graves Disease - immunology</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Receptors, Antigen, T-Cell, gamma-delta - immunology</subject><subject>T-Lymphocyte Subsets - immunology</subject><subject>Thyroid Gland - immunology</subject><issn>0009-9104</issn><issn>1365-2249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9LxDAQxYso67r6EYSc9FRo2vxpPQiy6CoseNFzmSZTN9ImtUmL_fZ2cRE9eRpm3psfb5ijaEkzweM0ZcVxtEySpIgLmrDT6Mz797kVQqSLaJGznBeUL6NxA20LRGMTgDRT2-2cmgJ6YixBq53qjUUCQ3CmbQdrwnRDcDQarULiaoKfHVhvnN0vbHoY0V8TbTyCR1INgVgX9lKYOiR0VqDCGX8endTQeLw41FX0-nD_sn6Mt8-bp_XdNu7mC0Jc17milRYFy2QGspYZSi1zwfh-hCyVCYW8QIlKAEOeYlWBVDmva4ocdbaKbr-53VC1qBXa0ENTdr1poZ9KB6b8q1izK9_cWFLOWZ6mM-DqAOjdx4A-lK3xCpsGLLrBl5LLOWlG_zVSwQqWUjEbL39H-slyeEn2BYvti-w</recordid><startdate>19930501</startdate><enddate>19930501</enddate><creator>Roura-Mir, I C</creator><creator>Alcalde, L</creator><creator>Vargas, F</creator><creator>Tolosa, E</creator><creator>Obiols, G</creator><creator>Foz, M</creator><creator>Jaraquemada, D</creator><creator>Pujol-Borrell, R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19930501</creationdate><title>Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes</title><author>Roura-Mir, I C ; Alcalde, L ; Vargas, F ; Tolosa, E ; Obiols, G ; Foz, M ; Jaraquemada, D ; Pujol-Borrell, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p224t-ff8c1bd694373a7f73e7d786456943e42701a89e7ec6a4e52ebba7c85ff1e5ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Autoimmune Diseases - immunology</topic><topic>Child</topic><topic>Diabetes Mellitus, Type 1 - immunology</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>Graves Disease - immunology</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Receptors, Antigen, T-Cell, gamma-delta - immunology</topic><topic>T-Lymphocyte Subsets - immunology</topic><topic>Thyroid Gland - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roura-Mir, I C</creatorcontrib><creatorcontrib>Alcalde, L</creatorcontrib><creatorcontrib>Vargas, F</creatorcontrib><creatorcontrib>Tolosa, E</creatorcontrib><creatorcontrib>Obiols, G</creatorcontrib><creatorcontrib>Foz, M</creatorcontrib><creatorcontrib>Jaraquemada, D</creatorcontrib><creatorcontrib>Pujol-Borrell, R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roura-Mir, I C</au><au>Alcalde, L</au><au>Vargas, F</au><au>Tolosa, E</au><au>Obiols, G</au><au>Foz, M</au><au>Jaraquemada, D</au><au>Pujol-Borrell, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes</atitle><jtitle>Clinical and experimental immunology</jtitle><addtitle>Clin Exp Immunol</addtitle><date>1993-05-01</date><risdate>1993</risdate><volume>92</volume><issue>2</issue><spage>288</spage><epage>295</epage><pages>288-295</pages><issn>0009-9104</issn><eissn>1365-2249</eissn><abstract>Endocrine autoimmune disorders are mediated by T cell-dependent responses to organ-specific antigens, but the mechanisms initiating the process remain unknown. Lymphocytes which use the gamma delta heterodimer as T cell receptor (TCR) for antigen constitute a distinct subset of T cells whose function remains elusive. In order to investigate their possible involvement in endocrine autoimmunity we have determined the proportion of gamma delta T cells in the peripheral blood of 23 patients with type 1 (insulin-dependent) diabetes mellitus (type-1 DM) and 30 patients with autoimmune thyrotoxicosis (Graves' disease). T lymphocyte TCR expression was assessed by fluorescence-activated flow cytometry on peripheral blood mononuclear cells using MoAbs UCHT1 (CD3), TCR delta 1 (gamma delta TCR), WT31 and beta F1 (alpha beta TCR) and both the percentage of T cells expressing gamma delta and the ratio gamma delta/alpha beta were calculated. In the diabetic patients gamma delta cells were not significantly different from the control group (7.7 +/- 54% versus 8.0 +/- 5.5% of T cells, P NS). There was no relation between the proportion of gamma delta lymphocytes and the presence of islet cell antibodies (ICA) in the sera. The Graves' patients showed a tendency towards a higher proportion of gamma delta T lymphocytes than the controls (gamma delta/alpha beta ratios: 0.095 +/- 0.047 versus 0.063 +/- 0.022, P = 0.03). In 14 Graves' patients the number of gamma delta were measured in paired samples of peripheral and intrathyroidal lymphocytes, demonstrating an expansion of gamma delta within the thyroid glands (0.21 +/- 0.3 versus 0.095 +/- 0.047, P = 0.032). Immunohistochemical studies showed that gamma delta cells were scattered among the predominant alpha beta lymphocytes infiltrating the thyroid gland and that they account for 10% of intraepithelial lymphocytes. No relation was found between the increase of gamma delta lymphocytes and any clinical features.</abstract><cop>England</cop><pmid>8485915</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9104
ispartof Clinical and experimental immunology, 1993-05, Vol.92 (2), p.288-295
issn 0009-9104
1365-2249
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1554822
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adolescent
Adult
Age Factors
Autoimmune Diseases - immunology
Child
Diabetes Mellitus, Type 1 - immunology
Female
Fluorescent Antibody Technique
Graves Disease - immunology
Humans
Immunophenotyping
Male
Middle Aged
Receptors, Antigen, T-Cell, gamma-delta - immunology
T-Lymphocyte Subsets - immunology
Thyroid Gland - immunology
title Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T04%3A25%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma%20delta%20lymphocytes%20in%20endocrine%20autoimmunity:%20evidence%20of%20expansion%20in%20Graves'%20disease%20but%20not%20in%20type%201%20diabetes&rft.jtitle=Clinical%20and%20experimental%20immunology&rft.au=Roura-Mir,%20I%20C&rft.date=1993-05-01&rft.volume=92&rft.issue=2&rft.spage=288&rft.epage=295&rft.pages=288-295&rft.issn=0009-9104&rft.eissn=1365-2249&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E75722431%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16494216&rft_id=info:pmid/8485915&rfr_iscdi=true